GSK Acquires Syndivia's Prostate Cancer ADC GSK has acquired the rights to Syndivia's preclinical antibody drug conjugate (ADC) for prostate cancer treatment. Despite having its own…
Meet the Next Generation of Physician Leaders at Rutgers Health In addition to their Ivy League pedigrees, Hailey Sulzbach's compassion, h…
Racial Disparities in Victim Compensation Families of Black homicide victims face higher denial rates for victim compensation claims, desp…
Pirates Top 30 Prospects: Zander Mueth Pittsburgh Pirates prospect Zander Mueth aims for an injury-free 2026 season. Mueth was draf…
Snapchat Democratizes AI Imaging Snapchat has made its first open prompt image-generation AI tool, "Imagine Lens", available to all U.S. u…
Disparities in PsA Burden and Treatment Linked to Geographic and Social Factors Disease activity and multimorbidity among patients in the …
Battlefield REDSEC Launch Battlefield Studios has confirmed the name and release date of its Battle Royale mode, titled Battlefield REDSEC…
D&H Distributing’s Advanced Solutions Plus Unit To Focus On The Enterprise D&H Distributing is unveiling Advanced Solutions Plus, a new bu…
Virgin Money Launches New Products Virgin Money has announced product changes, launching tomorrow (28 October), including two-year ERC fre…
BoltzGen Democratizes AI Therapeutic Design, Expands Druggable Universe The open-source model designs therapeutics across "any" modality w…
ACCC Sues Microsoft Over Alleged Misleading Subscription Practices The Australian Competition and Consumer Commission (ACCC) has filed a F…